Parties d'ouvrages collectifs (6)
3.
Desmet, R., Diesis, E., Drobecq, H., Rouanet, C., Chemlal, K., Debrie, A.-S., Hougardy, J.-M., Mascart, F., Locht, C., & Melnyk, O. (2010). In situ chemical modification of peptide microarrays.: Application to the study of the antibody responses to methylated antigens. In M. Uttamchandani & S. Yao (Eds.), Methods in Molecular Biology: Small Molecule Mircoarrays: Methods and Protocols (pp. 135-45). Humana Press/Springer.4.
Locht, C., Raze, D., Rouanet, C., Genisset, C., Segers, J., & Mascart, F. (2008). The mycobacterial heparin-binding hemagglutinin, virulence factor and antigen useful for diagnostics and vaccine development. In M. Daffe & J. Reyrat (Eds.), The Mycobacterial Cell Envelope (pp. 305-322). Washington DC: ASM Press.6.
Schandené, L., Ferster, A., Mascart, F., Goetghebuer, T., Marchant, A., Velu, T., Sariban, E., & Goldman, M. (1992). Imbalance in the production of interferon-gamma and interleukin-4 in a patient with Ommen's syndrome: rationale for interferon-gamma therapy. In New Advances on Cytokines (pp. 219-225). Raven Press.(Serono symposia publication). Articles dans des revues avec comité de lecture (194)
1.
Mascart, F., Hites, M., Watelet, E., Verschelden, G., Meuris, C. C., Doyen, J. L., Van Praet, A., Godefroid, A., Petit, E., Singh, M., Locht, C., & Corbiere, V. (2023). Analysis of a Combined HBHA and ESAT-6-Interferon-γ-Release Assay for the Diagnosis of Tuberculous Lymphadenopathies. Journal of Clinical Medicine, 12(6), 2127. doi:10.3390/jcm120621272.
Corbiere, V., Lambert, E. E., Rodesch, M., van Gaans-van den Brink, J. A. M., Misiak, A., Simonetti, E., Van Praet, A., Godefroid, A., Diavatopoulos, D. D., Van Els, C. A. C. M. C., & Mascart, F. (2023). A semi high-throughput whole blood-based flow cytometry assay to detect and monitor Bordetella pertussis-specific Th1, Th2 and Th17 responses. Frontiers in immunology, 14, 1101366. doi:10.3389/fimmu.2023.11013663.
Lavis, P., Morra, S., Orte Cano, C., Albayrak, N., Corbiere, V., Olislagers, V., Dauby, N., Del Marmol, V., Marchant, A., Decaestecker, C., Mascart, F., De Vos, N., Van De Borne, P., Salmon, I., Remmelink, M., Parmentier, M., Cardozo, A. K., & Bondue, B. (2022). Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality. Frontiers in immunology, 13, 941663. doi:10.3389/fimmu.2022.9416634.
Dirix, V., Dauby, N., Hites, M., Watelet, E., Van Praet, A., Godefroid, A., Petit, E., Singh, M., Locht, C., Mascart, F., & Corbiere, V. (2022). Optimal Detection of Latent Mycobacterium tuberculosis Infection by Combined Heparin-Binding Hemagglutinin (HBHA) and Early Secreted Antigenic Target 6 (ESAT-6) Whole-Blood Interferon Gamma Release Assays. Journal of clinical microbiology, 60(5), e0244321. doi:10.1128/jcm.02443-215.
Albayrak, N., Orte Cano, C., Karimi, S., Dogahe, D., Van Praet, A., Godefroid, A., Del Marmol, V., Grimaldi, D., Bondue, B., Van Vooren, J.-P., Mascart, F., & Corbiere, V. (2022). Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection. Frontiers in Immunology, 13. doi:10.3389/fimmu.2022.7698396.
Dirix, V., Collart, P., Van Praet, A., Hites, M., Dauby, N., Allard, S., Racapé, J., Singh, M., Locht, C., Mascart, F., & Corbiere, V. (2022). Immuno-Diagnosis of Active Tuberculosis by a Combination of Cytokines/Chemokines Induced by Two Stage-Specific Mycobacterial Antigens: A Pilot Study in a Low TB Incidence Country. Frontiers in immunology, 13, 842604. doi:10.3389/fimmu.2022.842604